Intrahepati̇c Cholestasis of Pregnancy

Kenyon AP, Piercy CN, Girling J, Williamson C, Tribe RM, Shennan AH. Obstetric cholestasis, outcome with active management: a series of 70 cases. Journal of Obstetrics and Gynaecology. 2002;109(3):282-8.

Svanborg A. A study of recurrent jaundice in pregnancy. Acta Obstetricia et Gynecologica Scandinavica . 1954; 33(4): 434-44.

Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstetrics and Gynecology. 2014; 124(1): 120-33.

Manzotti C, Casazza G, Stimac T,et al. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy. Cochrane Database of Systematic Reviews. 2019; 7: pCD012546

Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World Journal of Gastroenterology. 2009; 15(17): 2049-66.

Gao XX, Ye MY, Liu Y, et al. Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population. Scientific Reports. 2020; 10(1): 16307.

Jacquemin E, De Vree JM, Cresteil D, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology. 2001; 120(6): 1448-58.

Jacquemin E, Cresteil D, Manouvrier S, et al. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet. 1999; 353(9148): 210-1.

Bacq Y, Gendrot C, Perrotin F, Lefrou L, Chretien S, Vie-Buret V, et al. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. Journal of Medical Genetics. 2009; 46(10): 711-5.

Keitel V, Vogt C, Haussinger D, et al. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology. 2006;131(2):624-9.

Mutlu MF, Aslan K, Guler I, Mutlu I, Erdem M, Bozkurt N, et al. Two cases of first onset intrahepatic cholestasis of pregnancy associated with moderate ovarian hyperstimulation syndrome after IVF treatment and review of the literature. Obstetrics and Gynaecology. 2017; 37(5): 547-9.

Abu-Hayyeh S, Ovadia C, Lieu T, et al. Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology. 2016; 63(4): 1287-98.

Floreani A, Gervasi MT. New Insights on Intrahepatic Cholestasis of Pregnancy. Clinics in Liver Disease. 2016; 20(1): 177-89.

Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomäki KJH. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population‐based study. Hepatology. 2006; 43(4): 723-8.

Piechota J, Jelski W. Intrahepatic Cholestasis in Pregnancy: Review of the Literature. Clinical Medicine. 2020; 9(5): 1361.

Sahni A, Jogdand SD. Effects of Intrahepatic Cholestasis on the Foetus During Pregnancy. Cureus. 2022;14(10):e30657.

Gorelik J, Shevchuk A, De Swiet M, Lab M, Korchev Y, Williamson CJBAIJoO, et al. Comparison of the arrhythmogenic effects of tauro‐and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes. Journal of Obstetrics and Gynaecology . 2004; 111(8): 867-70.

Israel EJ, Guzman ML, Campos GA. Maximal response to oxytocin of the isolated myometrium from pregnant patients with intrahepatic cholestasis. Acta Obstetricia et Gynecologica Scandinavica. 1986; 65(6): 581-2.

Sepulveda WH, Gonzalez C, Cruz MA, et al. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. European Journal of Obstetrics & Gynecology and Reproductive Biology. 1991; 42(3): 211-5.

Geenes V, Lövgren-Sandblom A, Benthin L, et al. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid. PloS one. 2014;9(1):e83828.

Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019; 393(10174): 899-909.

Di Mascio D, Quist-Nelson J, Riegel M, et al. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review. Maternal Fetal Neonatal Medicine. 2021; 34(21): 3614-22.

Wood AM, Livingston EG, Hughes BL, et al. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management. Obstetrical & Gynecological Survey. 2018; 73(2): 103-9.

Geenes V, Chappell LC, Seed PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology. 2014; 59(4): 1482-91.

Williamson C, Miragoli M, Sheikh Abdul Kadir S, et al. Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy. Digestive Disease. 2011; 29(1): 58-61.

Williamson C, Hems LM, Goulis DG, et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. Obstetrics and Gynaecology. 2004; 111(7): 676-81.

Wensink MJ. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age: various objections. American Journal of Obstetrics & Gynecology .2016; 215(6): 807-8.

Saleh MM, Abdo KR. Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence. Womens Health (Larchmont). 2007; 16(6): 833-41.

Manna L, Ovadia C, Lövgren‐Sandblom A, et al. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study. Obstetrics & Gynaecology. 2019; 126(13): 1633-40.

Zhang Y, Lu L, Victor DW, et al. Ursodeoxycholic acid and S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy: a meta-analysis. Hepatitis Monthly. 2016;16(8): e38558

Coltorti M, Bortolini M, Di Padova C. A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis. Methods and Findings in Experimental Clinical and Pharmacology. 1990;12(1):69-78.

Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther. 2003;17(7):857-70.

Liu J, Murray AM, Mankus EB, et al. Adjuvant Use of Rifampin for Refractory Intrahepatic Cholestasis of Pregnancy. Obstetrics and Gynecology. 2018;132(3): 678-81.

Walker KF, Chappell LC, Hague WM, et al. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database System Revision. 2020;7(7): CD000493.

Cappell MS. Hepatic disorders mildly to moderately affected by pregnancy: medical and obstetric management. Medical Clinics of North America. 2008; 92(4): 717-737.

Lee RH, Incerpi MH, Miller DA, et al. Sudden fetal death in intrahepatic cholestasis of pregnancy. Obstetrics and Gynecology. 2009; 113(2 Pt 2): 528-531.

Sentilhes L, Verspyck E, Pia P, et al. Fetal death in a patient with intrahepatic cholestasis of pregnancy. Obstetrics and Gynecology. 2006;107(2 Pt 2): 458-60.

Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstetrics and Gynecology. 1999; 94(2): 189-93.

Girling J, Knight CL, Chappell L, et al. Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43 June 2022. Journal of Obstetrics and Gynaecology. 2022; 129(13): e95-e114.

Late-Preterm MI, Deliveries E-T. Obstetrics and Gynecology. ACOG Committee Opinion, Number 818. 2021;138(1): e35-9.

Furrer R, Winter K, Schaffer L, et al. Postpartum Blood Loss in Women Treated for Intrahepatic Cholestasis of Pregnancy. Obstetrics and Gynecology. 2016; 128(5): 1048-52.

Maldonado M, Alhousseini A, Awadalla M, Idler J, Welch R, Puder K, et al. Intrahepatic Cholestasis of Pregnancy Leading to Severe Vitamin K Deficiency and Coagulopathy. Case Reports inObstetrics and Gynecology. 2017; 2017: 5646247.